National Advertising Division Finds “Unbeatable 5G Reliability” Claim for Cox Mobile Supported
New York, NY – April 1, 2024 – In a challenge brought by AT&T Services, Inc., BBB National Programs’ National Advertising Division determined that Cox Communications Inc. provided a reasonable basis for the claim that Cox Mobile provides “Unbeatable 5G Reliability” as well as other express claims about its host network and implied claims about third-party testing of Cox Mobile.
The challenged “Unbeatable 5G Reliability” claims appeared in a 30-second television commercial and on the Cox Mobile website with a disclosure noting that “Cox Mobile runs on the network with unbeatable 5G reliability as measured by Ookla, LLC in the U.S., 1H 2023.”
In support of its “Unbeatable 5G Reliability” claims, Cox relied on RootMetrics’ Nationwide 5G testing, which assessed the performance of the three major carriers, AT&T, T-Mobile, and Verizon. Cox further relied on the additional testing conducted by RootMetrics in October 2023, which tested devices used by Cox Mobile customers. Cox also provided head-to-head 5G reliability testing of the MVNO, Cox Mobile, and its host network, Verizon.
After reviewing the evidence, the National Advertising Division (NAD) determined that Cox Mobile established a reasonable basis to support the claims:
- “Cox Mobile runs on the network with unbeatable 5G reliability”
- “We run on the network with unbeatable 5G reliability”
- “Cox Mobile runs on the network with unbeatable 5G reliability as measured by Ookla, LLC in the U.S.”
NAD further determined that the implied claim that Ookla, LLC has conducted testing of 5G reliability for Cox Mobile customers was supported.
In its advertiser statement, Cox stated that it “appreciates NAD’s recognition that its unbeatable 5G reliability claim is fully supported.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product
New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.
National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin
New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin.
In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products
New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.”
National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies
New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.